Kronos Bio Stock Forecast - Jensen Alpha

KRON Stock  USD 0.96  0.09  10.34%   
Kronos Stock Forecast is based on your current time horizon. Although Kronos Bio's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Kronos Bio's systematic risk associated with finding meaningful patterns of Kronos Bio fundamentals over time.
  
As of the 29th of November 2024, Payables Turnover is likely to grow to 1.06, while Inventory Turnover is likely to drop (0.41). . As of the 29th of November 2024, Common Stock Shares Outstanding is likely to drop to about 55.8 M. In addition to that, Net Loss is likely to drop to about (125.9 M).
On November 22, 2024 Kronos Bio had Jensen Alpha of 0.
Check Kronos Bio VolatilityBacktest Kronos BioTrend Details  

Kronos Bio Trading Date Momentum

On November 25 2024 Kronos Bio was traded for  0.89  at the closing time. The top price for the day was 0.92  and the lowest listed price was  0.88 . The trading volume for the day was 105.2 K. The trading history from November 25, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.11% . The trading delta at closing time against the current closing price is 3.33% .
Compare Kronos Bio to competition

Other Forecasting Options for Kronos Bio

For every potential investor in Kronos, whether a beginner or expert, Kronos Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kronos Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kronos. Basic forecasting techniques help filter out the noise by identifying Kronos Bio's price trends.

View Kronos Bio Related Equities

 Risk & Return  Correlation

Kronos Bio Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Kronos Bio's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Kronos Bio's current price.

Kronos Bio Market Strength Events

Market strength indicators help investors to evaluate how Kronos Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kronos Bio shares will generate the highest return on investment. By undertsting and applying Kronos Bio stock market strength indicators, traders can identify Kronos Bio entry and exit signals to maximize returns.

Kronos Bio Risk Indicators

The analysis of Kronos Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kronos Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kronos stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Kronos Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kronos Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will appreciate offsetting losses from the drop in the long position's value.

Moving against Kronos Stock

  0.71VTRS ViatrisPairCorr
  0.65ESPR Esperion TherapeuticsPairCorr
  0.65BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.65GILD Gilead SciencesPairCorr
  0.44EWTX Edgewise TherapeuticsPairCorr
The ability to find closely correlated positions to Kronos Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kronos Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kronos Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kronos Bio to buy it.
The correlation of Kronos Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kronos Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kronos Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kronos Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Kronos Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kronos Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kronos Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kronos Bio Stock:
Check out Historical Fundamental Analysis of Kronos Bio to cross-verify your projections.
To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.43)
Revenue Per Share
0.143
Quarterly Revenue Growth
0.442
Return On Assets
(0.28)
Return On Equity
(0.63)
The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.